This document appears to be page 2 of a CV for a high-level medical administrator or executive (likely associated with Mount Sinai). It details their work as a Global Health Project Leader (2002-2015), Director of Strategic Initiatives (2001-2002), and Assistant Dean (1998-2001). Key activities include coordinating Haiti earthquake relief with the Clinton Foundation and Partners in Health, negotiating the use of a Honeywell corporate jet, and managing significant medical missions in Liberia.
This document is a professional biography for Robin Solomon, detailing her extensive career at Mount Sinai Medical Center. It highlights her role in Donor Relations and Trustee Services, where she collaborated with major financial and legal firms (including Goldman Sachs) to generate over $20 million annually. The document also outlines her global health initiatives, including work with the Clinton office for Haiti relief and President Sirleaf in Liberia, as well as her background in clinical research and nursing. The document is stamped 'HOUSE_OVERSIGHT_015671', indicating it is part of a Congressional investigation.
This text details the World Health Organization's 2002 adoption of new MDR-TB treatment protocols modeled after Partners In Health's work, marking a victory for Jim Kim. It discusses the global fight against the twin pandemics of AIDS and TB, noting falling drug prices and shifting attitudes towards treating AIDS in impoverished areas. The excerpt concludes with Jim Kim's appointment as a senior adviser at the WHO in 2003 and the growing influence of the Zanmi Lasante project in Haiti.
This document contains excerpts from Tracy Kidder's book "Mountains Beyond Mountains," detailing the early work of Paul Farmer and Jim Yong Kim with Partners In Health (PIH). It highlights their unconventional methods, described as a "Robin Hood attitude," to obtain expensive drugs for treating multi-drug-resistant tuberculosis (MDR-TB) in Peru, often borrowing supplies from Brigham and Women's Hospital without guaranteed funding.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity